Acuta Capital Partners’s Cartesian Therapeutics RNAC Stock Holding History

Acuta Capital Partners’s Portfolio RNAC Stock Details RNAC Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$4.26M	Hold
2021 Q2	$4.28M	Buy
2021 Q1	$3.72M	Buy
2020 Q4	–	Sell
2020 Q3	$5.86M	Hold
2020 Q2	$6.71M	Hold
2020 Q1	$5.7M	Hold
2019 Q4	$5.34M	Buy